Beckman Coulter is committed to partnering with healthcare professionals to combat antimicrobial resistance. We can best address this growing global-health crisis together.

We've updated our previous forecast of antimicrobial-resistance profiles and combination-therapy options to advance new considerations for treating evolving infections.

We hope this guide supports your efforts as you explore new agents to fight multidrug-resistant organisms.